NeutroCure is a European Consortium

developing ways to control the spatial and temporal amplification of ROS generation to effectively treat severe pathological conditions characterised by a dysfunction in ROS homeostasis. These conditions include:

  • inflammatory and autoimmune diseases,
  • cancer and
  • myeloablation
Photos of PI’s of NeutroCure: upper row: A. Mokhir, M. Hoffmann, M. Herrmann, M. Hultquist, lower row: H. Griffiths, A. Hidalgo Alonso, R. Bilyy, G. Kroemer